TRACON Pharmaceutical (TCON) Tops Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts TCON Hot Sheet
Join SI Premium – FREE
TRACON Pharmaceutical (NASDAQ: TCON) reported Q2 EPS of ($0.31), $0.06 better than the analyst estimate of ($0.37).
For earnings history and earnings-related data on TRACON Pharmaceutical (TCON) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Are we witnessing a fundamental or speculative rally in the S&P 500?
- PVH Corp. (PVH) Tops Q1 EPS by 19c, Offers Guidance
- Jefferies, UBS downgrade Victoria's Secret as rally leaves limited upside
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
